Veracyte, Inc. (VCYT)
24.58
-0.46
(-1.84%)
USD |
NASDAQ |
Nov 20, 10:47
Veracyte Cash from Investing (Quarterly) : -139.47M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -139.47M |
| June 30, 2026 | -13.54M |
| March 31, 2026 | -127.96M |
| December 31, 2025 | -5.43M |
| September 30, 2025 | 48.26M |
| June 30, 2025 | -0.224M |
| March 31, 2025 | -51.82M |
| December 31, 2024 | -54.14M |
| September 30, 2024 | -2.242M |
| June 30, 2024 | -2.77M |
| March 31, 2024 | 2.878M |
| December 31, 2023 | -2.497M |
| September 30, 2023 | -2.802M |
| June 30, 2023 | -3.669M |
| March 31, 2023 | 24.08M |
| December 31, 2022 | -26.43M |
| September 30, 2022 | 8.807M |
| June 30, 2022 | -9.307M |
| March 31, 2022 | -2.453M |
| December 31, 2021 | 0.385M |
| September 30, 2021 | -165.46M |
| June 30, 2021 | 1.473M |
| March 31, 2021 | -575.61M |
| December 31, 2020 | -0.888M |
| September 30, 2020 | -1.635M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.649M |
| March 31, 2020 | -0.665M |
| December 31, 2019 | -41.10M |
| September 30, 2019 | -0.226M |
| June 30, 2019 | -0.658M |
| March 31, 2019 | -0.749M |
| December 31, 2018 | -0.454M |
| September 30, 2018 | -0.659M |
| June 30, 2018 | -0.534M |
| March 31, 2018 | -0.227M |
| December 31, 2017 | -0.30M |
| September 30, 2017 | -0.727M |
| June 30, 2017 | -0.113M |
| March 31, 2017 | -0.175M |
| December 31, 2016 | -0.45M |
| September 30, 2016 | -0.171M |
| June 30, 2016 | -0.614M |
| March 31, 2016 | -2.975M |
| December 31, 2015 | -4.19M |
| September 30, 2015 | -1.123M |
| June 30, 2015 | -0.944M |
| March 31, 2015 | -0.441M |
| December 31, 2014 | -0.533M |
| September 30, 2014 | -7.573M |
| June 30, 2014 | -0.78M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Teleflex, Inc. | 1.480B |
| West Pharmaceutical Services, Inc. | 78.90M |
| Globus Medical, Inc. | -155.90M |
| Illumina, Inc. | 50.00M |
| Inspire Medical Systems, Inc. | 17.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 40.26M |
| Cash from Financing (Quarterly) | -0.479M |
| Free Cash Flow | 161.95M |
| Free Cash Flow Per Share (Quarterly) | 0.4581 |
| Free Cash Flow to Equity (Quarterly) | 37.30M |
| Free Cash Flow to Firm (Quarterly) | 37.92M |
| Free Cash Flow Yield | 8.17% |